<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01639807</url>
  </required_header>
  <id_info>
    <org_study_id>AEH/SLT/012/2011</org_study_id>
    <nct_id>NCT01639807</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP</brief_title>
  <official_title>A Prospective, Randomized, Controlled Clinical Trial Comparing Topical Medical Therapy With Selective Laser Trabeculoplasty in South Indian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurolab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurolab</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare Selective laser trabeculoplasty (SLT) and topical
      medications for initial treatment of open-angle glaucoma /Ocular Hypertension based on
      intraocular pressure reduction, treatment side effects, quality of life measures and costs in
      South Indian Population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Selective laser trabeculoplasty (SLT), a lasering procedure, is equal to or better than using
      medication for lowering eye pressure,leading to a better quality of life and being less
      costly.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra Ocular Pressure</measure>
    <time_frame>24 months</time_frame>
    <description>To assess the mean and percentage reduction of Intra Ocular Pressure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
    <description>To assess the visual function and quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>latanoprost 2-8˚ C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>latanoprost(0.005%)stored at 2-8˚ C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Selective laser Trabeculoplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Latanoprost</intervention_name>
    <description>Latanoprost (0.005%) eye drops, once daily in the evening</description>
    <arm_group_label>latanoprost 2-8˚ C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SLT</intervention_name>
    <description>Selective Laser Trabeculoplasty</description>
    <arm_group_label>SLT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diagnosis: POAG, PXF glaucoma, pigmentary glaucoma or mixed mechanism POAG with a narrow
        angle, (if laser PI &gt; 3 months ago) defined by standard examination criteria Adequate
        visualization of angle structures (i.e. clear media and cooperative patient) On no glaucoma
        medications OU &gt; 1 month On no systemic medications known to IOP (steroids) Visual acuity &gt;
        6/24 OU Age - more than 35 yrs and less than 72 yrs

        Exclusion Criteria:

        A cumulative lifetime use of eye drops for glaucoma that exceeded 14 days; Used any eye
        drops for glaucoma in the 3 weeks before baseline I visit (washout from &lt; 14 days of use
        will be permitted); CIGTS visual field score that exceeds 16 in either eye; Evidence of
        ocular disease other than glaucoma that might affect the measurements of IOP, assessment of
        visual function, visual field testing Proliferative diabetic retinopathy Previous
        intraocular surgery one or both eyes except laser PI more than 3 months ago and cataract
        extraction with PC IOL more than 4 months ago.

        Undergone ophthalmic laser (other than laser PI &gt; 3 months ago), refractive, conjunctival,
        or intraocular surgery in either eye; Would likely require cataract surgery within 6 months
        of randomization Current or expected use of corticosteroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GEORGE V PUTHURAN, M.B.B.S, M.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital,Madurai.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625 020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DR. GEORGE V PUTHURAN, M.B.B.S,M.S</last_name>
      <phone>+91 0452 4356100</phone>
      <phone_ext>118</phone_ext>
      <email>george@aravind.org</email>
    </contact>
    <contact_backup>
      <last_name>M. Mohamed Hussian, M.Pharm</last_name>
      <phone>+91 0452 4356100</phone>
      <phone_ext>364</phone_ext>
      <email>clinicalresearch@aravind.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2012</study_first_submitted>
  <study_first_submitted_qc>July 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2012</study_first_posted>
  <last_update_submitted>July 11, 2012</last_update_submitted>
  <last_update_submitted_qc>July 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Open Angle Glaucoma or Ocular hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Latanoprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

